Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: Preliminary findings from an open trial

This open study assessed the ability of rivastigmine to treat the neuropsychiatric complications of advanced Parkinson's disease. In a group of 12 patients, hallucinations, sleep disturbance, and carer distress were all improved and cognitive performance significantly enhanced by the drug. © 2001 Movement Disorder Society.

[1]  B. Flourié,et al.  Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation , 1999, Gut.

[2]  N J Douglas,et al.  Under reporting of sleepiness and driving impairment in patients with sleep apnoea/hypopnoea syndrome , 1997, Journal of sleep research.

[3]  G. Plazzi,et al.  REM sleep behavior disorders in multiple system atrophy , 1997, Neurology.

[4]  D. Jeste,et al.  Psychotic Symptoms in Parkinson's Disease Patients with Dementia , 1996, Journal of the American Geriatrics Society.

[5]  M. Steriade.  Basic mechanisms of sleep generation , 1992, Neurology.

[6]  Murat Emre,et al.  Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study , 2000, The Lancet.

[7]  M. Hutchinson,et al.  Cholinesterase inhibition in Parkinson's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[8]  W Poewe,et al.  Botulinum toxin in writer's cramp: objective response evaluation in 31 patients. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[9]  C. Marsden,et al.  The anatomical basis of symptomatic hemidystonia. , 1985, Brain : a journal of neurology.

[10]  H. Klawans,et al.  Levodopa-induced psychosis: a kindling phenomenon. , 1978, The American journal of psychiatry.

[11]  C. Tanner,et al.  Polysomnographic sleep measures in Parkinson's disease patients with treatment‐induced hallucinations , 1993, Annals of neurology.

[12]  K. Rockwood,et al.  Donepezil for Treatment of Dementia With Lewy Bodies: A Case Series of Nine Patients , 1998, International Psychogeriatrics.

[13]  L. Schiller,et al.  Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lactulose. , 1989, The Journal of clinical investigation.

[14]  Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. , 1999, The New England journal of medicine.

[15]  D. Rye,et al.  FAST TRACK: daytime sleepiness in Parkinson's disease. , 2000, Journal of sleep research.

[16]  J. Lakke.  Art and Parkinson's disease. , 1999, Advances in neurology.

[17]  H. Haeske-Dewick.  Hallucinations in Parkinson's disease: Characteristics and associated clinical features , 1995 .

[18]  T. Mima,et al.  Electrophysiological studies of early stage corticobasal degeneration , 1998, Movement disorders : official journal of the Movement Disorder Society.

[19]  E. Tolosa,et al.  Stiff‐leg syndrome: A focal form of stiff‐man syndrome , 1998, Annals of neurology.

[20]  H U Rehman,et al.  Multiple system atrophy , 2001, Postgraduate medical journal.

[21]  D. Kaufer.  Beyond the Cholinergic Hypothesis: The Effect of Metrifonate and Other Cholinesterase Inhibitors on Neuropsychiatric Symptoms in Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[22]  H. Sagar,et al.  Olanzapine in the treatment of hallucinosis in idiopathic parkinson’s disease: a cautionary note , 1998, Journal of neurology, neurosurgery, and psychiatry.

[23]  Glenn T. Stebbins,et al.  Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease , 1998, Neurology.

[24]  M. Emre,et al.  Stiff leg syndrome: Case report , 2001, Movement disorders : official journal of the Movement Disorder Society.

[25]  Mark Hallett,et al.  Abnormal somatosensory homunculus in dystonia of the hand , 1998, Annals of neurology.

[26]  J. Kulisevsky,et al.  Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: A two‐year follow‐up study of previously untreated patients , 2000, Movement disorders : official journal of the Movement Disorder Society.

[27]  H. Shibasaki,et al.  REM sleep without atonia at early stage of sporadic olivopontocerebellar atrophy , 1995, Journal of the Neurological Sciences.

[28]  J. Friedman,et al.  Atypical antipsychotics in the treatment of drug‐induced psychosis in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[29]  M. Hallett,et al.  Symptomatic and essential palatal tremor. 3. Abnormal motor learning. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[30]  J. P. Brandel,et al.  Accuracy of the Clinical Diagnosis of Corticobasal Degeneration , 1997, Neurology.

[31]  C. Marsden,et al.  Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia , 1995, Annals of neurology.

[32]  C. Goetz,et al.  Pharmacology of hallucinations induced by long-term drug therapy. , 1982, The American journal of psychiatry.

[33]  C. G. Phillips.  THE BASAL GANGLIA AND THEIR RELATION TO DISORDERS OF MOVEMENT , 1962 .

[34]  F. Howard,et al.  Stiff-man syndrome updated. , 1989, Mayo Clinic proceedings.

[35]  C. Marsden,et al.  The stiff leg syndrome. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[36]  M. Hoehn.  Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole. , 2000, Neurology.

[37]  Genetics and biology: a comment on the significance of the Elston-Stewart algorithm. , 1992, Human heredity.

[38]  M. Hallett,et al.  Symptomatic and essential palatal tremor. 1. Clinical, physiological and MRI analysis. , 1994, Brain : a journal of neurology.

[39]  W M Jenkins,et al.  A primate genesis model of focal dystonia and repetitive strain injury , 1996, Neurology.

[40]  T. Aso,et al.  Subclinical REM sleep behavior disorder in a patient with corticobasal degeneration. , 1997, Sleep.

[41]  R. Rubin,et al.  Psychological, psychophysiological, and biochemical correlates of prolonged sleep deprivation. , 1969, The American journal of psychiatry.

[42]  S Fahn,et al.  Falling asleep at the wheel: Motor vehicle mishaps in persons taking pramipexole and ropinirole , 1999, Neurology.

[43]  E. Perry,et al.  Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial , 2000, International journal of geriatric psychiatry.

[44]  M. Merzenich,et al.  Sensory dysfunction associated with repetitive strain injuries of tendinitis and focal hand dystonia: a comparative study. , 1996, The Journal of orthopaedic and sports physical therapy.

[45]  W. Poewe,et al.  Premorbid personality of Parkinson patients. , 1983, Journal of neural transmission. Supplementum.

[46]  Mrinalini Honavar,et al.  Lewy bodies and response to tacrine in Alzheimer's disease , 1994, The Lancet.

[47]  T. Roth,et al.  Falling asleep at the wheel: motor vehicle mishaps in people taking pramipexole and ropinirole. , 2000, Neurology.

[48]  I Litvan,et al.  Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[49]  C D Marsden,et al.  Patterns of regional cerebral blood flow in corticobasal degeneration studied using HMPAO SPECT; comparison with Parkinson's disease and normal controls , 1995, Movement disorders : official journal of the Movement Disorder Society.

[50]  F Lhermitte,et al.  Cholinergic‐dependent cognitive deficits in Parkinson's disease , 1987, Annals of neurology.

[51]  O. Rascol,et al.  L-Dopa-induced sedation: a double-blind cross-over controlled study versus triazolam and placebo in healthy volunteers. , 1999, Clinical neuropharmacology.

[52]  A. Kleinschmidt,et al.  Dysfunctional activation of subcortical nuclei in palatal myoclonus detected by high‐resolution MRI , 1994, NMR in biomedicine.

[53]  W. Weiner,et al.  Sleep Disruption in the Course of Chronic Levodopa Therapy: An Early Feature of the Levodopa Psychosis , 1982, Clinical neuropharmacology.

[54]  J. Jankovic,et al.  Delayed-onset progressive movement disorders after static brain lesions , 1996, Neurology.

[55]  W. Koller,et al.  Usefulness of a writing aid in writer's cramp , 1989, Neurology.

[56]  W. Jost,et al.  Long‐term results with cisapride in Parkinson's disease , 1997, Movement disorders : official journal of the Movement Disorder Society.

[57]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[58]  P. Becker,et al.  Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. , 1993, Sleep.

[59]  S. Horiguchi,et al.  Early diagnosis and stage classification of vocal cord abductor paralysis in patients with multiple system atrophy. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[60]  I. A. Sharoqi.  Stiff-man syndrome. , 1998, Annals of Saudi medicine.

[61]  A. Lang,et al.  Dopamine agonists and antagonists in the treatment of idiopathic dystonia. , 1988, Advances in neurology.

[62]  C. Marsden,et al.  Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity , 1998, Journal of neurology, neurosurgery, and psychiatry.

[63]  R. Wyatt,et al.  Effect of L-Dopa on the Sleep of Man , 1970, Nature.

[64]  G. Wilcock,et al.  Tacrine for senile dementia of Alzheimer's or Lewy body type , 1994, The Lancet.

[65]  S. Fahn.  Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale , 1987 .

[66]  O. Witte,et al.  Oscillatory activity in different motor subsystems in palatal myoclonus. A case report , 1992, Acta neurologica Scandinavica.

[67]  P. Stern,et al.  Writer's cramp--a focal dystonia: etiology, diagnosis, and treatment. , 1993, The Journal of hand surgery.

[68]  P. Vieregge,et al.  Voluntary palatal tremor in two siblings , 1998, Movement disorders : official journal of the Movement Disorder Society.

[69]  M. Mega,et al.  Neuropsychiatric features of corticobasal degeneration , 1998, Journal of neurology, neurosurgery, and psychiatry.

[70]  C. Armon,et al.  Clinical neurophysiologic studies in stiff-man syndrome: use of simultaneous video-electroencephalographic-surface electromyographic recording. , 1990, Mayo Clinic proceedings.

[71]  B. Miller,et al.  Enhanced artistic creativity with temporal lobe degeneration , 1996, The Lancet.

[72]  I. Ziv,et al.  Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy. , 1996, Advances in neurology.

[73]  S. Chokroverty.  Sleep and degenerative neurologic disorders. , 1996, Neurologic clinics.

[74]  Joseph Friedman,et al.  Olanzapine in the treatment of dopaminomimetic psychosis in patients with Parkinson's disease , 1998, Neurology.

[75]  H. Shibasaki,et al.  Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's cramp , 1995, Muscle & nerve.

[76]  C. Goetz.  Coexisting tardive dyskinesia and parkinsonian symptoms. , 1982, The American journal of psychiatry.

[77]  H. Freund,et al.  Sensorimotor disturbances in patients with lesions of the parietal cortex. , 1989, Brain : a journal of neurology.

[78]  J. Mclean,et al.  Subacute encephalomyelitis presenting as stiff‐person syndrome: Clinical, polygraphic, and pathologic correlations , 1996, Movement disorders : official journal of the Movement Disorder Society.

[79]  C. Marsden,et al.  The behavioural and motor consequences of focal lesions of the basal ganglia in man. , 1994, Brain : a journal of neurology.

[80]  T. Ebner,et al.  Spatial patterns of functional activation of the cerebellum investigated using high field (4 T) MRI , 1994, NMR in biomedicine.

[81]  R. Hauser,et al.  Pramipexole‐induced somnolence and episodes of daytime sleep , 2000, Movement Disorders.

[82]  S. Leurgans,et al.  Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease , 1999, Movement disorders : official journal of the Movement Disorder Society.

[83]  C. Ballard,et al.  Neuropsychiatric aspects of alzheimer’s disease , 1999, Current psychiatry reports.

[84]  K. Schimrigk,et al.  Cisapride treatment of constipation in parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[85]  S. Chokroverty,et al.  Autonomic dysfunction and sleep apnea in olivopontocerebellar degeneration. , 1984, Archives of neurology.

[86]  R. Allen,et al.  A double-blind, placebo-controlled study of the treatment of periodic limb movements in sleep using carbidopa/levodopa and propoxyphene. , 1993, Sleep.

[87]  J. Cummings.  Managing psychosis in patients with Parkinson's disease. , 1999, New England Journal of Medicine.

[88]  C. Marsden,et al.  The stiff man and stiff man plus syndromes , 1999, Journal of Neurology.

[89]  R. Ranawaya,et al.  Usefulness of a writing device in writer's cramp , 1991, Neurology.

[90]  Jane S. Paulsen,et al.  Neuropsychiatric assessment of patients with hyperkinetic and hypokinetic movement disorders. , 1998, Archives of neurology.

[91]  W C Dement,et al.  The Sleep Disorders Questionnaire. I: Creation and multivariate structure of SDQ. , 1994, Sleep.

[92]  K. Jellinger,et al.  The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[93]  L Parrino,et al.  The cyclic alternating pattern plays a gate-control on periodic limb movements during non-rapid eye movement sleep. , 1996, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[94]  G. Sue,et al.  [Use of polyethylene glycol in the treatment of puerperal constipation]. , 1995, Gen.

[95]  A. Leis.  Cutaneous silent period , 1998, Muscle & nerve.

[96]  W. T. Thach,et al.  Palatal Myoclonus and Function of the Inferior Olive: Are They Related? , 1989 .

[97]  M. D. Freedman,et al.  Tolerance And Efficacy of Polyethylene Glycol 3350/Electrolyte Solution Versus Lactulose In Relieving Opiate Induced Constipation: A Double‐Blinded Placebo‐Controlled Trial , 1997, Journal of clinical pharmacology.

[98]  I. McKeith,et al.  Olanzapine in dementia with Lewy bodies: a clinical study , 1999, International journal of geriatric psychiatry.

[99]  M. Hallett,et al.  Increased glucose metabolism in the medulla of patients with palatal myoclonus , 1991, Neurology.

[100]  M. H. Ross,et al.  Treatment of occupational cramp with botulinum toxin: Diffusion of toxin to adjacent noninjected muscles , 1997, Muscle & nerve.

[101]  R. Watts,et al.  Juvenile Parkinson’s disease with REM sleep behavior disorder, sleepiness, and daytime REM onset , 1999, Neurology.

[102]  T. Roth,et al.  Waking up to sleep episodes in Parkinson's Disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[103]  S. Fahn,et al.  Sleep episodes in Parkinson's disease: A wake‐up call , 2000, Movement disorders : official journal of the Movement Disorder Society.

[104]  J. Cummings,et al.  Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. , 1999, Archives of neurology.

[105]  S. Priebe.  Levodopa Dependence: A Case Report , 1984, Pharmacopsychiatry.

[106]  D. C. Williams.  Periodic limb movements of sleep and the restless legs syndrome. , 1996, Virginia medical quarterly : VMQ.

[107]  R. Manni,et al.  Hallucinations, REM sleep, and Parkinson’s disease: A medical hypothesis , 2001, Neurology.

[108]  J. Pearce.  Longus cervicis colli "myositis" (syn: retropharyngeal tendinitis) , 1996, Journal of neurology, neurosurgery, and psychiatry.

[109]  G. Fénelon,et al.  Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. , 2000, Brain : a journal of neurology.

[110]  C. Guilleminault,et al.  Olivopontocerebellar degeneration, abnormal sleep, and REM sleep without atonia , 1986, Neurology.

[111]  S. Fahn.  Systemic Therapy of Dystonia , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[112]  A. Schapira.  Sleep attacks (sleep episodes) with pergolide , 2000, The Lancet.

[113]  M. Okawa,et al.  REM Sleep without Muscle Atonia (Stage 1‐REM) and Its Relation to Delirious Behavior during Sleep in Patients with Degenerative Diseases Involving the Brain Stem , 1990, The Japanese journal of psychiatry and neurology.

[114]  C. Adler,et al.  Biofeedback for writer's cramp. , 1997, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[115]  R. Daroff,et al.  The International Classification of Sleep Disorders , 1991, Neurology.

[116]  C D Marsden,et al.  Corticobasal degeneration: A clinical study of 36 cases , 1994 .

[117]  S. Tufik,et al.  Incidence of periodic leg movements and of the restless legs syndrome during sleep following acute physical activity in spinal cord injury subjects , 1996, Spinal Cord.

[118]  A. Bonnet,et al.  [The Unified Parkinson's Disease Rating Scale]. , 2000, Revue neurologique.

[119]  S. Gilman,et al.  Positive and negative factors in movement control: A current review of Denny-Brown's hypothesis , 1997, Journal of the Neurological Sciences.

[120]  E. Wolpert.  A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. , 1969 .

[121]  J. Sanchez-Ramos,et al.  Visual hallucinations associated with Parkinson disease. , 1996, Archives of neurology.

[122]  C Trenkwalder,et al.  Cerebral generators involved in the pathogenesis of the restless legs syndrome , 1997, Annals of neurology.

[123]  O. Rascol,et al.  Sleep attacks and Parkinson's disease treatment , 2000, The Lancet.